Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy.

Autor: Bamias A; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece; 2nd Propaedeutic Dept of Internal Medicine, ATTIKON Hospital, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: abamias@med.uoa.gr., Tzannis K; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece., Dimitriadis I; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tsironis G; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece., Papatheorodidi AM; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tsiara A; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece., Fragkoulis C; Department of Urology, Athens General Hospital 'G. Gennimatas,' Athens, Greece., Xirokosta A; Hematology Division, Alexandra Hospital, Athens, Greece., Barbarousi D; Hematology Division, Alexandra Hospital, Athens, Greece., Papadopoulos G; Department of Urology, Athens General Hospital 'G. Gennimatas,' Athens, Greece., Zakopoulou R; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece., Varkarakis I; 2nd Department of Urology, Sismanoglio General Hospital, University of Athens, Athens, Greece., Mitsogiannis I; 2nd Department of Urology, Sismanoglio General Hospital, University of Athens, Athens, Greece., Adamakis I; 1st University Urology Clinic, Laiko Hospital, University of Athens, Athens, Greece., Alamanis C; 1st University Urology Clinic, Laiko Hospital, University of Athens, Athens, Greece., Stravodimos K; 1st University Urology Clinic, Laiko Hospital, University of Athens, Athens, Greece., Papatsoris AG; 2nd Department of Urology, Sismanoglio General Hospital, University of Athens, Athens, Greece., Dellis AE; 2nd Department of Surgery, Aretaieion Academic Hospital, University of Athens, Athens, Greece., Drivalos A; Department of Urology, Athens General Hospital 'Elpis,' Athens, Greece., Ntoumas K; Department of Urology, Athens General Hospital 'G. Gennimatas,' Athens, Greece., Matsouka H; Hematology Division, Alexandra Hospital, Athens, Greece., Halvatsiotis P; 2nd Propaedeutic Dept of Internal Medicine, ATTIKON Hospital, National and Kapodistrian University of Athens, Athens, Greece., Raptis A; 2nd Propaedeutic Dept of Internal Medicine, ATTIKON Hospital, National and Kapodistrian University of Athens, Athens, Greece., Gerotziafas GT; Cancer Biology and Therapeutics, INSERM U938, Institut Universitaire de Cancérologie (IUC), Faculté de Médecine Pierre et Marie Curie, Université Pierre et Marie Curie (UPMC), Sorbonne Universités, Paris, France., Dimopoulos MA; Hematology-Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Aug; Vol. 18 (4), pp. e457-e472. Date of Electronic Publication: 2020 Jan 08.